Cetera Investment Advisers’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Cetera Investment Advisers's BTAL Position: Q2 2026 in Review
Cetera Investment Advisers reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 2.7% in Q2 2026, selling an estimated $4.27K and leaving 12,755 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #4594.
Cetera Investment Advisers first reported a position in BTAL in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.26M in Q1 2023. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Cetera Investment Advisers held 12,755 shares of AGF US Market Neutral Anti-Beta Fund worth $142K as of Q2 2026.
- Cetera Investment Advisers sold 351 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $4.27K.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4594 holding.
- Cetera Investment Advisers first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and has held it in 15 quarters since.
- Cetera Investment Advisers's AGF US Market Neutral Anti-Beta Fund position peaked at $3.26M in Q1 2023.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.